Detection of insulin mRNA in the peripheral blood after human islet transplantion predicts deterioration of metabolic control

American Journal of Transplantation

Volumn 6, Issue 7, 2006, Pages 1704-1711

  Berney, T ^a   Mamin, A ^a   James Shapiro, A M ^b   Ritz Laser, B ^a   Brulhart, M C ^a   Toso, C ^a   Demuylder Mischler, S ^a   Armanet, M ^a   Baertschiger, R ^a   Wojtusciszyn, A ^a   Benhamou, P Y ^c   Bosco, D ^a   Morel, P ^a   Philippe, J ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF ALBERTA   (Canada)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Graft function; Islet transplantation; Monitoring; Reverse transcriptase PCR

Indexed keywords

INSULIN; MESSENGER RNA;

ADULT; ARTICLE; BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; DETERIORATION; FEMALE; GRAFT FAILURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MALE; METABOLIC REGULATION; PANCREAS ISLET TRANSPLANTATION; PATIENT MONITORING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION;

ADULT; FEMALE; GRAFT SURVIVAL; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LEUKOCYTES; MALE; MIDDLE AGED; RNA, MESSENGER;

EID: 33745332679     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01373.x     Document Type: Article

References (35)

1. Shapiro AMJ Lakey JRT Ryan E et al. Islet transplantation in seven patients with type 1 diabetes mellitus using steroid-free immunosuppression regimen. N Engl J Med 2000 343 : 230 238.
2. Ryan EA Paty BW Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060 2069.
3. Molano RD Berney T Li H et al. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell co-stimulation. Diabetes 2001 50 : 270 276.
4. Jaeger C Brendel MD Eckhard M Bretzel RG. Islet autoantibodies as potential markers for disease recurrence in clinical islet transplantation. Exp Clin Endocrinol Diabetes 2000 108 : 328 333.
5. Ricordi C Zeng YJ Alejandro R et al. In vivo effects of FK506 on human pancreatic islets. Transplantation 1991 52 : 519 522.
6. Paty BW Harmon JS Marsh CL Robertson RP. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 2002 73 : 353 357.
7. Bell E Cao X Moibi JA et al. Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets. Diabetes 2003 52 : 2731 2739.
8. Ryan EA Lakey JRT Rajotte RV et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001 50 : 710 719.
9. Bottino R Fernandez LA Ricordi C et al. Transplantation of allogeneic islets of Langerhans in the rat liver: Effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 1998 47 : 316 323.
10. Cattan P Berney T Schena S et al. Early assessment of apoptosis in isolated islets of Langerhans. Transplantation 2001 71 : 857 862.
11. Li X Chen H Epstein PN. Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species. J Biol Chem 2004 279 : 765 771.
12. Bottino R Balamurugan AN Tse H et al. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004 53 : 2259 2268.
13. Berney T Molano RD Cattan P et al. Endotoxin-mediated delayed islet graft function is associated with increased intra-islet cytokine production and islet cell apoptosis. Transplantation 2001 71 : 125 132.
14. Ritz-Laser B Oberholzer J Toso C et al. Molecular detection of circulating β-cells after islet transplantation. Diabetes 2002 51 : 557 561.
15. Lee TC Barshes NR Brunicardi FC et al. Procurement of the human pancréas for pancreatic islet isolation. Transplantation 2004 78 : 481 483.
16. Ricordi C Lacy PE Finke EH et al. Automated method for isolation of human pancreatic islets. Diabetes 1988 37 : 413 420.
17. Bucher P Mathe Z Morel P et al. Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation 2005 79 : 91 97.
18. Berney T Pileggi A Molano R Ricordi C. Pancreatic islet cells. In : Atala A Lanza R, eds. Methods of tissue engineering. San Diego : Academic Press, 2001 : 203 218.
19. Goss JA Soltes G Goodpastor SE et al. Pancreatic islet transplantation: The radiographic approach. Transplantation 2003 76 : 199 203.
20. Berney T Ricordi C. Islet transplantation: The future? Langenbecks Arch Surg 2000 385 : 373 378.
21. Wang J Shen L Najafi H et al. Regulation of insulin preRNA splicing by glucose. Proc Natl Acad Sci U S A 1997 94 : 4360 4365.
22. Pileggi A Ricordi C Alessiani M Inverardi L. Factors influencing islet of Langerhans graft function and monitoring. Clin Chim Acta 2001 310 : 3 16.
23. Shapiro AMJ Hao EG Lakey JRT et al. Novel approaches toward early diagnosis of islet allograft rejection. Transplantation 2001 71 : 1709 1718.
24. Olack BJ Swanson CJ Flavin KS et al. Sensitization to HLA antigens in islet recipients with failing transplants. Transplant Proc 1997 29 : 2268 2269.
25. Bosi E Braghi S Maffi P et al. Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 2001 50 : 2464 2471.
26. Roep BO Stobbe I Duinkerken G et al. Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes 1999 48 : 484 490.
27. Reijonen H Kwok WW Nepom GT. Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers. Ann N Y Acad Sci 2003 1005 : 82 87.
28. Mallone R Nepom GT. MHC class II tetramers and the pursuit of antigen-specific T cells: Define, deviate, delete. Clin Immunol 2003 110 : 232 242.
29. Paty BW Bonner-Weir S Laughlin MR McEwan AJ Shapiro AM. Toward development of imaging modalities for islets after transplantation: Insights from the National Institutes of Health Workshop on Beta Cell Imaging. Transplantation 2004 77 : 1133 1137.
30. Jirak D Kriz J Herynek V et al. MRI of transplanted pancreatic islets. Magn Reson Med 2004 52 : 1228 1233.
31. Han D Xu X Pastori RL Ricordi C Kenyon NS. Elevation of cytotoxic lymphocyte gene expression is predictive of islet allograft rejection in nonhuman primates. Diabetes 2002 51 : 562 566.
32. Han D Xu X Baidal D et al. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients. Elevation precedes clinical evidence of rejection. Diabetes 2004 53 : 2281 2290.
33. Bennet W Sundberg B Groth CG et al. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 1999 48 : 1907 1914.
34. Davalli AM Scaglia L Zangen DH et al. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996 45 : 1161 1167.
35. Menger MD Yamauchi J Vollmar B. Revascularization and microcirculation of freely grafted islets of Langerhans. World J Surg 2001 25 : 509 515.